Cargando…

Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Zhang, Jingxin, Deng, Guodong, Qiao, Lili, Luo, Hui, Liu, Qiqi, Liang, Ning, Xie, Jian, Zhang, Jiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312980/ https://www.ncbi.nlm.nih.gov/pubmed/30655823 http://dx.doi.org/10.3892/ol.2018.9643

Ejemplares similares

Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells
por: Zhang, Jingxin, et al.
Publicado: (2018)

The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions
por: Liu, Qiqi, et al.
Publicado: (2016)

Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma
por: Zhang, Jingxin, et al.
Publicado: (2017)

Advanced research on vasculogenic mimicry in cancer
por: Qiao, Lili, et al.
Publicado: (2015)

Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells
por: QIAO, LILI, et al.
Publicado: (2016)

Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer
por: Zhang, Jingxin, et al.
Publicado: (2017)

Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer
por: You, Xiaolan, et al.
Publicado: (2018)

Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling
por: You, Xiaolan, et al.
Publicado: (2019)

Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023)

Retracted: Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry
por: Healthcare Engineering, Journal of
Publicado: (2023)

Galectin-1 promotes vasculogenic mimicry in gastric adenocarcinoma via the Hedgehog/GLI signaling pathway
por: You, Xiaolan, et al.
Publicado: (2020)

Vasculogenic mimicry in carcinogenesis and clinical applications
por: Luo, Qingxi, et al.
Publicado: (2020)

Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
por: Liu, Qiqi, et al.
Publicado: (2017)

Effect of galectin-3 on the behavior of Eca-109 human esophageal cancer cells
por: LIANG, NING, et al.
Publicado: (2015)

Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer
por: Deng, Guodong, et al.
Publicado: (2016)

Retraction Notice to: Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis
por: Wang, Di, et al.
Publicado: (2022)

A Novel Bispecific Immunotoxin Delivered by Human Bone Marrow-Derived Mesenchymal Stem Cells to Target Blood Vessels and Vasculogenic Mimicry of Malignant Gliomas [Retraction]
Publicado: (2021)

Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
por: Ayala-Domínguez, Lízbeth, et al.
Publicado: (2019)

An Overview of Vasculogenic Mimicry in Breast Cancer
por: Andonegui-Elguera, Marco A., et al.
Publicado: (2020)

Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

FOXM 1 induces Vasculogenic mimicry in esophageal cancer through β-catenin /Tcf4 signaling
por: Cheng, Lili, et al.
Publicado: (2020)

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
por: Wei, Xiaoxu, et al.
Publicado: (2021)

Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies
por: Deng, Guodong, et al.
Publicado: (2017)

Vasculogenic mimicry in small cell lung cancer
por: Williamson, Stuart C., et al.
Publicado: (2016)

Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes
por: Zhang, Chao, et al.
Publicado: (2016)

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry
por: Zhang, Xue, et al.
Publicado: (2019)

Overview of advances in vasculogenic mimicry – a potential target for tumor therapy
por: Ge, Hong, et al.
Publicado: (2018)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Slug promoted vasculogenic mimicry in hepatocellular carcinoma
por: Sun, Dan, et al.
Publicado: (2013)

Structural and functional identification of vasculogenic mimicry in vitro
por: Racordon, Dusan, et al.
Publicado: (2017)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Platelets disrupt vasculogenic mimicry by cancer cells
por: Martini, Carmela, et al.
Publicado: (2020)

Advance in vasculogenic mimicry in ovarian cancer (Review)
por: Tian, Xinyuan, et al.
Publicado: (2023)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer
por: Han, Cong, et al.
Publicado: (2017)

The effect of induction chemotherapy in patients with locally advanced nonsmall cell lung cancer who received chemoradiotherapy: A systematic review and meta-analysis
por: Luo, Hui, et al.
Publicado: (2017)

The prognostic value of cytotoxic T-lymphocyte antigen 4 in cancers: a systematic review and meta-analysis
por: Hu, Pingping, et al.
Publicado: (2017)

Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma
por: Zhang, Shiwu, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_b0dgtf3a3fcpak2qp8a1f4b084